Description
The debate identified lack of selective OR2 agonists and unknown effects on microglial phenotypes as major barriers. Understanding this dual pathway could enable simultaneous sleep and inflammation targeting.
Source: Debate session sess_SDA-2026-04-01-gap-v2-18cf98ca (Analysis: SDA-2026-04-01-gap-v2-18cf98ca)